Quantifying the Impact of COVID-19 on Cancer Patients: A Technical Report of Patient Experience During the COVID-19 Pandemic at a High-volume Radiation Oncology Proton Center in New York City

Press, Robert H.; Hasan, Shaakir; Chhabra, Arpit; Choi, J. Isabelle; Simone, Charles B.

doi:10.7759/cureus.7873

Cited by 8 publications

(33 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, we identified 62 studies that fully met our inclusion criteria. 2 , 39 - 59 , 60 - 80 , 81 - 99 The flowchart of the process of study identification and selection is presented in Figure 1 .…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Riera

Bagattini

Pacheco

et al. 2021

JCO Global Oncology

336

263

View full text Add to dashboard Cite

PURPOSE There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Methodological quality assessment of the included studies and reasons for judgment are presented in the Data Supplement. The methodological quality was considered low for case series, 43 , 45 low for longitudinal studies, 47 , 70 , 80 and moderate 2 , 48 , 75 to low 56 , 93 for cross-sectional studies.…”

Section: Resultsmentioning

confidence: 99%

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Riera

Bagattini

Pacheco

et al. 2021

JCO Global Oncology

336

263

View full text Add to dashboard Cite

show abstract

“…In the oncology subspecialties, there has been a broad adoption and implementation of virtual cancer care, including dramatic shifts in workflow across many radiation oncology practices. 5 , 6 , 7 , 8 Given that these drastic changes occurred in response to a public health emergency, it is unclear what long-lasting effects will remain after the COVID-19 pandemic and the degree to which health care institutions will continue to rely on (or insurance companies will reimburse) telemedicine in the future. An important component to answering this relies on understanding the experience of those delivering these telemedicine visits, and the advantages and difficulties they face that might influence their future decisions to continue offering telemedicine services.…”

Section: Discussionmentioning

confidence: 99%

A National Survey of Radiation Oncology Experiences Completing Tele-Consultations During the Coronavirus Disease (COVID-19) Pandemic

Chhabra¹,

Chowdhary²,

Choi³

et al. 2021

Advances in Radiation Oncology

Self Cite

View full text Add to dashboard Cite

“…In the absence of both data and homogenous higher-level guidelines, cancer therapy centers and individual radiation therapy departments have created their own guidelines and this is reflected in the publications uncovered in this review. Important insights originate in virus epicenters like Italy [8], New York in the US [9,10]. According to a survey by Opperman et al, who conducted an online survey among medical physicists in Germany, Austria and Switzerland from March 23rd to 26th 2020, 72.4% of the respondents stated that their processes were affected due to COVID-19, with longer processing times (54.2%), patient no-shows (42.5%) and staff reduction (36.7%).…”

Section: Logistical and Operational Focused Publications Logistics Anmentioning

confidence: 99%

“…This publication also presents patient data and addresses approaches to toxicity management in the context of COVID-19. Press et al also described a single institution experience from a proton center in Manhattan quantifying the impact of treatment delays and interruptions [9]. Chhabra et al also provide recommendations for prioritization of proton patient in the New York Proton Center [55].…”

Section: Single Center Experiencesmentioning

confidence: 99%

https://researchopenworld.com/management-of-cancer-patients-undergoing-radiation-therapy-during-the-novel-coronavirus-disease-2019-covid-19-pandemic-a-review-of-the-literature/#

2020

Cancer Stud Ther J

View full text Add to dashboard Cite

systemic management and may therefore not necessarily be immunecompromised, as well as the implication for daily attendance to a RT facility and the associated infection risk and how to best mitigate it. Other questions involve the ability to and safety of delaying or altering RT treatment schedules to minimize risk of infection. Important additional considerations abound in particular settings such a RT emergencies and treatment of the COVID-19 positive patient as well as the administration of radioactive isotopes such as radioactive iodine in thyroid patients who then need to self-isolate at home or as inpatients for several days. Since the COVID-19 pandemic has raised unprecedented challenges and questions, with ongoing lack of robust data, periodic review of the available evidence is important to help guide providers and patients in order to enable evidence-based care hence prompting this scoping review. Materials and Methods To carry out the scoping review, publications that specifically addressed the impact and management of cancer patients undergoing radiation therapy in the context of the COVID 19 pandemic were identified in PubMed using the following mesh terms: (("risk"[MeSH Terms] OR "risk"[All Fields]) OR "risk of "[All Fields]) AND ((((((("covid 19"[All Fields] OR "covid 2019"[All Fields]) OR "severe acute respiratory syndrome coronavirus 2"[Supplementary Concept]) OR "severe acute respiratory syndrome coronavirus 2"[All Fields]) OR "2019 ncov"[All Fields]) OR "sars cov 2"[All Fields]) OR "2019ncov"[All Fields]

show abstract

Quantifying the Impact of COVID-19 on Cancer Patients: A Technical Report of Patient Experience During the COVID-19 Pandemic at a High-volume Radiation Oncology Proton Center in New York City

Cited by 8 publications

References 10 publications

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

A National Survey of Radiation Oncology Experiences Completing Tele-Consultations During the Coronavirus Disease (COVID-19) Pandemic

https://researchopenworld.com/management-of-cancer-patients-undergoing-radiation-therapy-during-the-novel-coronavirus-disease-2019-covid-19-pandemic-a-review-of-the-literature/#

Contact Info

Product

Resources

About